NCT06833008
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06833008
Title A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ipsen
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP

Facility Status City State Zip Country Details
START Mid-West RECRUITING Grand Rapids Michigan 49546 United States Details
Sarah Cannon Research Institute (SCRI) - Nashville RECRUITING Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Centers - Medical City Hospital - Dallas RECRUITING Dallas Texas 75230 United States Details
START Mountan Region RECRUITING West Valley City Utah 84119 United States Details
Virginia Cancer Specialist- Fairfax RECRUITING Fairfax Virginia 22031 United States Details
Centre Léon Bérard - Lyon NOT_YET_RECRUITING Lyon France Details
Paris Saint-Louis RECRUITING Paris France Details
IGR-Villejuif NOT_YET_RECRUITING Villejuif France Details
Istituto Nazionale dei Tumori RECRUITING Milan Italy Details
Istituto Nazionale Tumori IRCCS - Fondazione Pascale RECRUITING Napoli Italy Details
Val D'Hebron RECRUITING Barcelona Spain Details
Hospital Universitario Quirónsalud Madrid RECRUITING Madrid Spain Details
M.D. Anderson Center Madrid NOT_YET_RECRUITING Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field